Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 17 OCTOBER 2025

How Legal Ops Teams Slashed Contract Turnaround Time By 40% Using CLM

Melento
Explore more from Melento

A faster turnaround time is now a strategic necessity for every business, not just an operational benefit. Organizations across sectors are redefining success by how quickly they move from design to build and go-to-market.

GlobalCorporate/Commercial Law
Melento
Melento
Author LinkedIn connections

A faster turnaround time is now a strategic necessity for every business, not just an operational benefit. Organizations across sectors are redefining success by how quickly they move from design to build and go-to-market.

Despite being legal and compliance accelerators, Legal operation teams have long battled with contract bottlenecks. Manual reviews, fragmented data, endless email threads, and compliance challenges. These challenges led to missed opportunities, delayed revenue, and eroded value.

This has changed within organizations. In recent times, organizations have integrated Contract Lifecycle Management (CLM) solutions into their workflows. But they are still far from full adoption. A report by Legal Suite released in 2023, less than 10% of organizations have implemented digital systems to streamline contract management, while over 50% have no current plans to do so. Over the past couple of years, the numbers have grown significantly, but CLM has much

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Healthcare Trends & Transactions Q2 2026

Healthcare M&A activity maintained steady momentum through Q2 2026, driven by physician practice consolidation, AI-enabled technology acquisitions, and strategic outpatient expansion. Private equity investment persisted despite intensifying regulatory scrutiny of MSO arrangements, while digital health buyers paid significant premiums for platforms demonstrating production-grade AI capabilities and proprietary data assets.
United StatesCorporate/Commercial Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

CLIENT ALERT: 2026 Mid-Year Update On SEC And CFTC Enforcement

The SEC and CFTC have fundamentally shifted their enforcement approach in 2026, moving away from high-volume technical violations toward targeted actions addressing serious fraud and market manipulation. This mid-year update examines new leadership priorities, enhanced inter-agency coordination, revised cooperation policies, the elimination of "no-deny" settlement provisions, and a landmark Supreme Court ruling on disgorgement that collectively reshape the regulatory landscape for market participants.
United StatesCorporate/Commercial Law
Sher Tremonte
Sher Tremonte
Article

Sanofi And Regeneron Expand Immunology Collaboration In Deal Worth Up To $8 Billion

Sanofi and Regeneron Pharmaceuticals announce a major expansion of their immunology partnership, committing up to $8 billion to develop and commercialize four long-acting antibodies targeting key inflammatory pathways. The collaboration includes a $1 billion upfront payment and milestone-based payments, with both companies sharing development costs and future profits equally.
United StatesCorporate/Commercial Law
Goodwin Procter LLP
Goodwin Procter LLP